| Year |
Citation |
Score |
| 2013 |
Ferris S, Karantzoulis S, Somogyi M, Meng X. Rivastigmine in moderately severe-to-severe Alzheimer's disease: Severe Impairment Battery factor analysis. Alzheimer's Research & Therapy. 5: 63. PMID 24351447 DOI: 10.1186/alzrt229 |
0.3 |
|
| 2013 |
Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PS. Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. Neuropsychology. 27: 391-401. PMID 23876113 DOI: 10.1037/A0032707 |
0.328 |
|
| 2012 |
Benitez A, Fieremans E, de Fatima Falangola M, Ferris S, Jensen J, Helpern JA. P3-158: Cognitive processing speed and diffusional kurtosis imaging (DKI) in normal aging, mild cognitive impairment (MCI), and Alzheimer's disease (AD) Alzheimer's & Dementia. 8: P506-P507. DOI: 10.1016/j.jalz.2012.05.1378 |
0.314 |
|
| 2011 |
Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li C, Goldman R. Identifying amnestic mild cognitive impairment in primary care: a feasibility study. Clinical Drug Investigation. 31: 483-91. PMID 21627337 DOI: 10.2165/11588810-000000000-00000 |
0.334 |
|
| 2010 |
Harvey PD, Ferris SH, Cummings JL, Wesnes KA, Hsu C, Lane RM, Tekin S. Evaluation of dementia rating scales in Parkinson's disease dementia. American Journal of Alzheimer's Disease and Other Dementias. 25: 142-8. PMID 19359706 DOI: 10.1177/1533317509333904 |
0.317 |
|
| 2010 |
Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Holtoff V, Sternberg K, Tennigkeit F. The Relevant Outcome Scale for Alzheimer's Disease (ROSA): A new instrument for daily medical practice Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1165 |
0.329 |
|
| 2008 |
De Santi S, Pirraglia E, Barr W, Babb J, Williams S, Rogers K, Glodzik L, Brys M, Mosconi L, Reisberg B, Ferris S, de Leon MJ. Robust and Conventional Neuropsychological Norms: Diagnosis and Prediction of Age-Related Cognitive Decline Neuropsychology. 22: 469-484. PMID 18590359 DOI: 10.1037/0894-4105.22.4.469 |
0.341 |
|
| 2008 |
Myers CE, Kluger A, Golomb J, Gluck MA, Ferris S. Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 21: 93-103. PMID 18474718 DOI: 10.1177/0891988708316858 |
0.329 |
|
| 2007 |
Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. The Lancet. Neurology. 6: 501-12. PMID 17509485 DOI: 10.1016/S1474-4422(07)70109-6 |
0.32 |
|
| 2007 |
Ferris S, Schneider L, Farmer M, Kay G, Crook T. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI). International Journal of Geriatric Psychiatry. 22: 448-55. PMID 17117395 DOI: 10.1002/Gps.1711 |
0.312 |
|
| 2006 |
Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders. 20: S191-202. PMID 17135812 DOI: 10.1097/01.Wad.0000213875.63171.87 |
0.339 |
|
| 2006 |
Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Disease and Associated Disorders. 20: S139-46. PMID 17135807 DOI: 10.1097/01.Wad.0000213871.40300.68 |
0.314 |
|
| 2006 |
Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Disease and Associated Disorders. 20: S109-23. PMID 17135805 DOI: 10.1097/01.Wad.0000213870.40300.21 |
0.312 |
|
| 2006 |
Prichep LS, John ER, Ferris SH, Rausch L, Fang Z, Cancro R, Torossian C, Reisberg B. Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiology of Aging. 27: 471-81. PMID 16213630 DOI: 10.1016/j.neurobiolaging.2005.07.021 |
0.351 |
|
| 2005 |
Crook TH, Ferris SH, Alvarez XA, Laredo M, Moessler H. Effects of N-PEP-12 on memory among older adults. International Clinical Psychopharmacology. 20: 97-100. PMID 15729085 |
0.342 |
|
| 2004 |
Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology. 61: 59-66. PMID 14732621 DOI: 10.1001/Archneur.61.1.59 |
0.375 |
|
| 2003 |
Ferris SH. General measures of cognition. International Psychogeriatrics. 15: 215-7. PMID 16191243 DOI: 10.1017/S1041610203009220 |
0.337 |
|
| 2003 |
Ferris SH, Yan B. Differential diagnosis and clinical assessment of patients with severe Alzheimer disease. Alzheimer Disease and Associated Disorders. 17: S92-5. PMID 14512823 |
0.301 |
|
| 2003 |
Grundman M, Jack CR, Petersen RC, Kim HT, Taylor C, Datvian M, Weiner MF, DeCarli C, DeKosky ST, van Dyck C, Darvesh S, Yaffe K, Kaye J, Ferris SH, Thomas RG, et al. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. Journal of Molecular Neuroscience : Mn. 20: 241-8. PMID 14501003 DOI: 10.1385/Jmn:20:3:241 |
0.373 |
|
| 2002 |
Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Möbius HJ, Stöffler A. Measuring cognition in advanced Alzheimer's disease for clinical trials. Journal of Neural Transmission. Supplementum. 135-48. PMID 12456059 DOI: 10.1007/978-3-7091-6139-5_14 |
0.304 |
|
| 2002 |
Yesavage JA, O'Hara R, Kraemer H, Noda A, Taylor JL, Ferris S, Gély-Nargeot MC, Rosen A, Friedman L, Sheikh J, Derouesné C. Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. Journal of Psychiatric Research. 36: 281-6. PMID 12127595 DOI: 10.1016/S0022-3956(02)00020-1 |
0.322 |
|
| 2002 |
Myers CE, Kluger A, Golomb J, Ferris S, de Leon MJ, Schnirman G, Gluck MA. Hippocampal atrophy disrupts transfer generalization in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 15: 82-90. PMID 12083598 |
0.324 |
|
| 1999 |
Kluger A, Ferris SH, Golomb J, Mittelman MS, Reisberg B. Neuropsychological prediction of decline to dementia in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 12: 168-79. PMID 10616864 DOI: 10.1177/089198879901200402 |
0.361 |
|
| 1999 |
Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV, Pasquier F, Moroney JT, Ferris SH, Stern Y, Sachdev PS, Hachinski VC. The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Disease and Associated Disorders. 13: S21-9. PMID 10609678 DOI: 10.1097/00002093-199912001-00005 |
0.358 |
|
| 1997 |
Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S13-21. PMID 9236948 |
0.376 |
|
| 1997 |
Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S1-12. PMID 9236947 |
0.334 |
|
| 1997 |
De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, De Santi S, McRae T, Ferris SH, Reisberg B, Ince C, Rusinek H, Bobinski M, Quinn B, Miller DC, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiology of Aging. 18: 1-11. PMID 8983027 DOI: 10.1016/S0197-4580(96)00213-8 |
0.375 |
|
| 1996 |
Colomb J, Kluger A, De Leon MJ, Ferris SH, Mittelman M, Cohen J, George AE. Hippocampal formation size predicts declining memory performance in normal aging Neurology. 47: 810-813. PMID 8797485 DOI: 10.1212/WNL.47.3.810 |
0.352 |
|
| 1996 |
Ferris SH, Kluger A. Commentary on age-associated memory impairment, age-related cognitive decline and mild cognitive impairment Aging Neuropsychology and Cognition. 3: 148-153. DOI: 10.1080/13825589608256620 |
0.37 |
|
| 1994 |
Golomb J, Kluger A, de Leon MJ, Ferris SH, Convit A, Mittelman MS, Cohen J, Rusinek H, De Santi S, George AE. Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learning & Memory (Cold Spring Harbor, N.Y.). 1: 45-54. PMID 10467585 |
0.337 |
|
| 1994 |
Golomb J, de Leon MJ, George AE, Kluger A, Convit A, Rusinek H, de Santi S, Litt A, Foo SH, Ferris SH. Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 590-3. PMID 8201330 DOI: 10.1136/jnnp.57.5.590 |
0.32 |
|
| 1994 |
Prichep LS, John ER, Ferris SH, Reisberg B, Almas M, Alper K, Cancro R. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiology of Aging. 15: 85-90. PMID 8159266 DOI: 10.1016/0197-4580(94)90147-3 |
0.342 |
|
| 1993 |
Flicker C, Ferris SH, Reisberg B. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 6: 84-96. PMID 8512635 DOI: 10.1177/089198879300600205 |
0.377 |
|
| 1993 |
Flicker C, Ferris SH, Reisberg B. A longitudinal study of cognitive function in elderly persons with subjective memory complaints. Journal of the American Geriatrics Society. 41: 1029-32. PMID 8409146 DOI: 10.1111/j.1532-5415.1993.tb06448.x |
0.357 |
|
| 1993 |
Golomb J, de Leon MJ, Kluger A, George AE, Tarshish C, Ferris SH. Hippocampal atrophy in normal aging. An association with recent memory impairment. Archives of Neurology. 50: 967-73. PMID 8363451 DOI: 10.1001/Archneur.1993.00540090066012 |
0.31 |
|
| 1992 |
Flicker C, Ferris SH, Serby M. Hypersensitivity to scopolamine in the elderly. Psychopharmacology. 107: 437-41. PMID 1615141 DOI: 10.1007/bf02245172 |
0.402 |
|
| 1992 |
Crook TH, Ferris SH. Age associated memory impairment. Bmj (Clinical Research Ed.). 304: 714. PMID 1489381 DOI: 10.1136/bmj.304.6828.714-b |
0.323 |
|
| 1991 |
Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 41: 1006-9. PMID 2067629 DOI: 10.1212/wnl.41.7.1006 |
0.403 |
|
| 1991 |
Kluger A, Ferris SH. Scales for the assessment of Alzheimer's disease. The Psychiatric Clinics of North America. 14: 309-26. PMID 2062723 |
0.303 |
|
| 1990 |
Flicker C, Ferris SH, Crook T, Bartus RT. Impaired facial recognition memory in aging and dementia. Alzheimer Disease and Associated Disorders. 4: 43-54. PMID 2317337 DOI: 10.1097/00002093-199040100-00005 |
0.594 |
|
| 1990 |
Flicker C, Serby M, Ferris SH. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology. 100: 243-50. PMID 2305013 DOI: 10.1007/bf02244414 |
0.381 |
|
| 1989 |
Flicker C, Ferris SH, Crook T, Bartus RT. Age differences in the vulnerability of facial recognition memory to proactive interference. Experimental Aging Research. 15: 189-94. PMID 2638638 DOI: 10.1080/03610738908259774 |
0.567 |
|
| 1988 |
Flicker C, Ferris SH, Crook T, Reisberg B, Bartus RT. Equivalent spatial-rotation deficits in normal aging and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 10: 387-99. PMID 3403702 DOI: 10.1080/01688638808408247 |
0.565 |
|
| 1988 |
Reisberg B, Ferris SH, de Leon MJ, Franssen ESE, Kluger A, Mir P, Borenstein J, George AE, Shulman E, Steinberg G, Cohen J. Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment and primary degenerative dementia of the Alzheimer type Drug Development Research. 15: 101-114. DOI: 10.1002/Ddr.430150203 |
0.341 |
|
| 1987 |
Flicker C, Ferris SH, Crook T, Bartus RT. A visual recognition memory test for the assessment of cognitive function in aging and dementia. Experimental Aging Research. 13: 127-32. PMID 3691582 DOI: 10.1080/03610738708259313 |
0.622 |
|
| 1987 |
Flicker C, Ferris SH, Crook T, Bartus RT. Implications of memory and language dysfunction in the naming deficit of senile dementia. Brain and Language. 31: 187-200. PMID 3620899 DOI: 10.1016/0093-934X(87)90069-1 |
0.571 |
|
| 1986 |
Reisberg B, Ferris SH, Shulman E, Steinberg G, Buttinger C, Sinaiko E, Borenstein J, De Leon MJ, Cohen J. Longitudinal course of normal aging and progressive dementia of the Alzheimer's type: A prospective study of 106 subjects over a 3.6 year mean interval Progress in Neuropsychopharmacology and Biological Psychiatry. 10: 571-578. PMID 3797687 DOI: 10.1016/0278-5846(86)90026-6 |
0.351 |
|
| 1986 |
Reisberg B, Ferris SH, Franssen E, Kluger A, Borenstein J. Age-Associated Memory Impairment: The Clinical Syndrome Developmental Neuropsychology. 2: 401-412. DOI: 10.1080/87565648609540357 |
0.347 |
|
| 1986 |
Flicker C, Ferris SH, Reisberg B, Crook T, Bartus RT. Cognitive Decline in Advanced Age: Future Directions for the Psychometric Differentiation of Normal and Pathological Age Changes in Cognitive Function Developmental Neuropsychology. 2: 309-322. DOI: 10.1080/87565648609540351 |
0.531 |
|
| 1986 |
Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-Associated Memory Impairment: Proposed Diagnostic Criteria and Measures of Clinical Change—Report of a National Institute of Mental Health Work Group Developmental Neuropsychology. 2: 261-276. DOI: 10.1080/87565648609540348 |
0.516 |
|
| 1986 |
Flicker C, Ferris SH, Crook T, Bartus RT. The Effects of Aging and Dementia on Concept Formation As Measured on an Object-Sorting Task Developmental Neuropsychology. 2: 65-72. DOI: 10.1080/87565648609540328 |
0.555 |
|
| 1985 |
Flicker C, Dean R, Bartus RT, Ferris SH, Crook T. Animal and human memory dysfunctions associated with aging, cholinergic lesions, and senile dementia. Annals of the New York Academy of Sciences. 444: 515-7. PMID 3860113 DOI: 10.1111/J.1749-6632.1985.Tb37630.X |
0.534 |
|
| 1984 |
Flicker C, Bartus RT, Crook TH, Ferris SH. Effects of aging and dementia upon recent visuospatial memory. Neurobiology of Aging. 5: 275-83. PMID 6531065 DOI: 10.1016/0197-4580(84)90003-4 |
0.602 |
|
| 1982 |
Reisberg MDB, Ferris SH, Schneck MK, Corwin J, Mir P, Friedman E, Sherman KA, McCarthy M, Bartus RT. Piracetam in the treatment of cognitive impairment in the elderly Drug Development Research. 2: 475-480. DOI: 10.1002/Ddr.430020508 |
0.544 |
|
| 1981 |
Ferris SH, Crook T, Clark E, McCarthy M, Rae D. Facial recognition memory deficits in normal aging and senile dementia. Journal of Gerontology. 35: 707-14. PMID 7430567 DOI: 10.1093/GERONJ/35.5.707 |
0.432 |
|
| 1981 |
McCarthy M, Ferris SH, Clark E, Crook T. Acquisition and retention of categorized material in normal aging and senile dementia. Experimental Aging Research. 7: 127-35. PMID 7274319 DOI: 10.1080/03610738108259795 |
0.384 |
|
| 1981 |
Friedman E, Sherman KA, Ferris SH, Reisberg B, Bartus RT, Schneck MK. Clinical response to choline plus piracetam in senile dementia: relation to red-cell choline level. The New England Journal of Medicine. 304: 1490-1. PMID 7231482 DOI: 10.1056/NEJM198106113042413 |
0.478 |
|
| 1981 |
Ferris SH, Crook T, Bartus RT. Meeting report. Workshop on assessment for geriatric psychopharmacology Neurobiology of Aging. 2: 319-322. DOI: 10.1016/0197-4580(81)90042-7 |
0.424 |
|
| 1977 |
Ferris SH, Sathananthan G, Gershon S, Clark C. Senile dementia: treatment with deanol. Journal of the American Geriatrics Society. 25: 241-4. PMID 864168 DOI: 10.1111/j.1532-5415.1977.tb00407.x |
0.355 |
|
| 1977 |
Ferris SH, Sathananthan G, Gershon S, Clark C, Moshinsky J. Cognitive effects of ACTH 4-10 in the elderly. Pharmacology, Biochemistry, and Behavior. 5: 73-8. PMID 189334 DOI: 10.1016/0091-3057(76)90332-4 |
0.378 |
|
| 1974 |
Bartus RT, Ferris SH. Neural correlates of habituation and dark adaptation in the visual cortex of the rat Physiological Psychology. 2: 55-59. DOI: 10.3758/BF03332992 |
0.396 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Schmitt FA, Saxton J, Ferris SH, Mackell J, Sun Y. Evaluation of an 8-item Severe Impairment Battery (SIB-8) vs. the full SIB in moderate to severe Alzheimer's disease patients participating in a donepezil study. International Journal of Clinical Practice. 67: 1050-6. PMID 24073978 DOI: 10.1111/ijcp.12188 |
0.299 |
|
| 1996 |
Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 47: 705-11. PMID 8797468 DOI: 10.1212/Wnl.47.3.705 |
0.299 |
|
| 1997 |
Kluger A, Gianutsos JG, Golomb J, Ferris SH, George AE, Franssen E, Reisberg B. Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 52: P28-39. PMID 9008673 DOI: 10.1093/Geronb/52B.1.P28 |
0.298 |
|
| 1977 |
Crook T, Ferris S, Sathananthan G, Raskin A, Gershon S. The effect of methylphenidate on test performance in the cognitively impaired aged. Psychopharmacology. 52: 251-5. PMID 406627 DOI: 10.1007/BF00426708 |
0.298 |
|
| 1999 |
Ferris SH. Cognitive outcome measures. Alzheimer Disease and Associated Disorders. 13: S140-2. PMID 10609693 |
0.296 |
|
| 1987 |
Miller JD, de Leon MJ, Ferris SH, Kluger A, George AE, Reisberg B, Sachs HJ, Wolf AP. Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 248-51. PMID 3494029 DOI: 10.1038/Jcbfm.1987.50 |
0.296 |
|
| 2005 |
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England Journal of Medicine. 352: 2379-88. PMID 15829527 DOI: 10.1056/Nejmoa050151 |
0.295 |
|
| 2008 |
Reisberg B, Ferris SH, Kluger A, Franssen E, Wegiel J, de Leon MJ. Mild cognitive impairment (MCI): a historical perspective. International Psychogeriatrics / Ipa. 20: 18-31. PMID 18031593 DOI: 10.1017/S1041610207006394 |
0.295 |
|
| 2009 |
Ferris S, Lane R, Sfikas N, Winblad B, Farlow M, Feldman HH. Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach. Gender Medicine. 6: 345-55. PMID 19682661 DOI: 10.1016/J.Genm.2009.06.004 |
0.295 |
|
| 2005 |
Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, Assaid C, Nessly ML, Norman BA, Baranak CC, Reines SA. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1204-15. PMID 15742005 DOI: 10.1038/sj.npp.1300690 |
0.295 |
|
| 1982 |
Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. The American Journal of Psychiatry. 139: 1136-9. PMID 7114305 DOI: 10.1176/AJP.139.9.1136 |
0.295 |
|
| 2010 |
Zhu C, Sano M, Ferris S, Aisen P. Assessing Health Related Resource use in Normal Elders and Subjects With Mild Cognitive Impairment Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.103 |
0.294 |
|
| 2008 |
Aisen PS, Thal LJ, Ferris SH, Assaid C, Nessly ML, Giuliani MJ, Lines CR, Norman BA, Potter WZ. Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial. Current Alzheimer Research. 5: 73-82. PMID 18288935 DOI: 10.2174/156720508783884602 |
0.292 |
|
| 1986 |
de Leon MJ, la Regina ME, Ferris SH, Gentes CI, Miller JD. Reduced incidence of left-handedness in clinically diagnosed dementia of the Alzheimer type. Neurobiology of Aging. 7: 161-4. PMID 3724949 DOI: 10.1016/0197-4580(86)90037-0 |
0.291 |
|
| 1997 |
Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S65-9. PMID 9236955 |
0.291 |
|
| 1997 |
Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S51-6. PMID 9236953 |
0.289 |
|
| 1997 |
Koss E, Weiner M, Ernesto C, Cohen-Mansfield J, Ferris SH, Grundman M, Schafer K, Sano M, Thal LJ, Thomas R, Whitehouse PJ. Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S45-50. PMID 9236952 DOI: 10.1097/00002093-199700112-00007 |
0.287 |
|
| 2009 |
Ferris S, Nordberg A, Soininen H, Darreh-Shori T, Lane R. Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment. Pharmacogenetics and Genomics. 19: 635-46. PMID 19617863 DOI: 10.1097/Fpc.0B013E32832F8C17 |
0.287 |
|
| 1997 |
Kluger A, Gianutsos JG, Golomb J, Ferris SH, Reisberg B. Motor/psychomotor dysfunction in normal aging, mild cognitive decline, and early Alzheimer's disease: diagnostic and differential diagnostic features. International Psychogeriatrics. 9: 307-16; discussion 3. PMID 9447451 DOI: 10.1017/S1041610297005048 |
0.283 |
|
| 2002 |
Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dementia and Geriatric Cognitive Disorders. 13: 217-24. PMID 12006732 DOI: 10.1159/000057700 |
0.282 |
|
| 2015 |
Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument. Jama Neurology. 72: 446-54. PMID 25706191 DOI: 10.1001/Jamaneurol.2014.3375 |
0.281 |
|
| 1997 |
Sano M, Mackell JA, Ponton M, Ferreira P, Wilson J, Pawluczyk S, Pfeiffer E, Thomas RG, Jin S, Schafer K, Schittini M, Grundman M, Ferris SH, Thal LJ. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S57-64. PMID 9236954 |
0.281 |
|
| 2004 |
Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, Tekin S, Lane R, Ferris S. Behavioral symptoms in mild cognitive impairment. Neurology. 62: 1199-201. PMID 15079026 DOI: 10.1212/01.WNL.0000118301.92105.EE |
0.279 |
|
| 2013 |
Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimer's Research & Therapy. 5: 58. PMID 24257331 DOI: 10.1186/Alzrt222 |
0.276 |
|
| 1985 |
Reisberg B, Ferris SH, Crook T. Guidelines for Drug Trials in the Treatment of Age-Associated Cognitive Decline and Alzheimer's Disease Drug Information Journal. 19: 405-420. DOI: 10.1177/009286158501900404 |
0.275 |
|
| 2013 |
Holthoff V, Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Sternberg K, Tennigkeit F. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study. International Journal of Geriatric Psychiatry. 28: 164-72. PMID 22492589 DOI: 10.1002/Gps.3805 |
0.275 |
|
| 2014 |
Banks SJ, Raman R, He F, Salmon DP, Ferris S, Aisen P, Cummings J. The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline. Dementia and Geriatric Cognitive Disorders Extra. 4: 509-16. PMID 25685141 DOI: 10.1159/000357775 |
0.273 |
|
| 1996 |
Reisberg B, Ferris SH, Franssen EH, Shulman E, Monteiro I, Sclan SG, Steinberg G, Kluger A, Torossian C, de Leon MJ, Laska E. Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study. International Psychogeriatrics / Ipa. 8: 291-311. PMID 8994898 DOI: 10.1017/S1041610296002657 |
0.272 |
|
| 1997 |
Ferris SH, Kluger A. Assessing cognition in Alzheimer disease research. Alzheimer Disease and Associated Disorders. 11: 45-9. PMID 9437447 |
0.271 |
|
| 2004 |
Reisberg B, Laska E, Monteiro I, Boksay I, Torossian C, Javed A, Amjadullah Khan M, Ferris S. S2-02-01 Predicting MCI and dementia in elderly subjects with subjective complaints Neurobiology of Aging. 25: S26. DOI: 10.1016/S0197-4580(04)80085-X |
0.271 |
|
| 1997 |
Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope. Alzheimer Disease & Associated Disorders. 11: 13-21. DOI: 10.1097/00002093-199700112-00003 |
0.27 |
|
| 1980 |
Crook T, Gilbert JG, Ferris S. Operationalizing memory impairment for elderly persons: the Guild Memory Test. Psychological Reports. 47: 1315-8. PMID 7220760 DOI: 10.2466/pr0.1980.47.3f.1315 |
0.27 |
|
| 2006 |
Cummings JL, Raman R, Ernstrom K, Salmon D, Ferris SH. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials. Alzheimer Disease and Associated Disorders. 20: S147-51. PMID 17135808 DOI: 10.1097/01.Wad.0000213872.17429.0F |
0.268 |
|
| 2000 |
Galasko DR, Schmitt FA, Jin S, Saxton J, Bennett D, Sano M, Ferris SH. Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 168. DOI: 10.1016/S0197-4580(00)82096-5 |
0.265 |
|
| 1978 |
Raskin A, Gershon S, Crook TH, Sathananthan G, Ferris S. The effects of hyperbaric and normobaric oxygen on cognitive impairment in the elderly. Archives of General Psychiatry. 35: 50-6. PMID 619839 DOI: 10.1001/ARCHPSYC.1978.01770250052005 |
0.265 |
|
| 2013 |
Falangola MF, Jensen JH, Tabesh A, Hu C, Deardorff RL, Babb JS, Ferris S, Helpern JA. Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease Magnetic Resonance Imaging. 31: 840-846. PMID 23602730 DOI: 10.1016/J.Mri.2013.02.008 |
0.264 |
|
| 1997 |
Schmitt FA, Ashford W, Ernesto C, Saxton J, Schneider LS, Clark CM, Ferris SH, Mackell JA, Schafer K, Thal LJ. The Severe Impairment Battery Alzheimer Disease & Associated Disorders. 11: 51-56. DOI: 10.1097/00002093-199700112-00008 |
0.262 |
|
| 2003 |
Reisberg B, Ferris SH, Oo T, Franssen E. Staging: relevance for trial design in vascular burden of the brain. International Psychogeriatrics. 15: 231-9. PMID 16191246 DOI: 10.1017/S1041610203009256 |
0.262 |
|
| 1979 |
Ferris SH, Sathananthan G, Reisberg B, Gershon S. Long-term choline treatment of memory-impaired elderly patients. Science (New York, N.Y.). 205: 1039-40. PMID 472728 DOI: 10.1126/science.472728 |
0.261 |
|
| 1997 |
Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 11: S22-32. PMID 9236949 DOI: 10.1097/00002093-199700112-00004 |
0.26 |
|
| 1989 |
Georgotas A, McCue RE, Reisberg B, Ferris SH, Nagachandran N, Chang I, Mir P. The Effects of Mood Changes and Antidepressants on the Cognitive Capacity of Elderly Depressed Patients International Psychogeriatrics. 1: 135-143. DOI: 10.1017/S1041610289000141 |
0.26 |
|
| 2009 |
Schneider LS, Raman R, Schmitt FA, Doody RS, Insel P, Clark CM, Morris JC, Reisberg B, Petersen RC, Ferris SH. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ for mild cognitive impairment clinical trials. Alzheimer Disease and Associated Disorders. 23: 260-7. PMID 19812469 DOI: 10.1097/Wad.0B013E31819Cb760 |
0.259 |
|
| 1981 |
Reisberg B, Ferris SH, Gershon S. An overview of pharmacologic treatment of cognitive decline in the aged. The American Journal of Psychiatry. 138: 593-600. PMID 7015883 DOI: 10.1176/AJP.138.5.593 |
0.256 |
|
| 2017 |
Li C, Neugroschl J, Luo X, Zhu C, Aisen P, Ferris S, Sano M. The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28854503 DOI: 10.3233/Jad-161294 |
0.254 |
|
| 2009 |
Gauthier S, Aisen PS, Ferris SH, Saumier D, Duong A, Haine D, Garceau D, Suhy J, Oh J, Lau W, Sampalis J. Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study. The Journal of Nutrition, Health & Aging. 13: 550-7. PMID 19536424 DOI: 10.1007/S12603-009-0106-X |
0.248 |
|
| 2008 |
Fokkens J, Ferris S, Robert P, Winblad B, Gauthier S. P3-009: Development of a language assessment tool for patients with Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1572 |
0.246 |
|
| 1985 |
Reisberg B, Ferris SH, Franssen E. An ordinal functional assessment tool for Alzheimer's-type dementia. Hospital & Community Psychiatry. 36: 593-5. PMID 4007814 DOI: 10.1176/PS.36.6.593 |
0.246 |
|
| 1991 |
Kluger A, Ferris SH. Scales for the Assessment of Alzheimer's Disease Psychiatric Clinics of North America. 14: 309-326. DOI: 10.1016/S0193-953X(18)30309-5 |
0.245 |
|
| 1994 |
Flicker C, Ferris SH, Kalkstein D, Serby M. A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease. The American Journal of Psychiatry. 151: 126-9. PMID 8267111 DOI: 10.1176/ajp.151.1.126 |
0.243 |
|
| 2015 |
Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, et al. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. Jama Neurology. 1-10. PMID 26414022 DOI: 10.1001/Jamaneurol.2015.0607 |
0.241 |
|
| 2010 |
Cummings JL, Ferris SH, Farlow MR, Olin JT, Meng X. Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis. Dementia and Geriatric Cognitive Disorders. 29: 406-12. PMID 20502014 DOI: 10.1159/000296073 |
0.24 |
|
| 1995 |
Golomb J, Kluger A, Gianutsos J, Ferris SH, de Leon MJ, George AE. Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clinics of North America. 5: 33-44. PMID 7743083 |
0.239 |
|
| 2008 |
Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18: 289-98. PMID 18334913 DOI: 10.1097/Fpc.0B013E3282F63F29 |
0.237 |
|
| 1996 |
Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, Reisberg B, Schmitt FA. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. Journal of Geriatric Psychiatry and Neurology. 9: 176-80. PMID 8970010 DOI: 10.1177/089198879600900404 |
0.236 |
|
| 2012 |
Ihl R, Ferris S, Robert P, Winblad B, Gauthier S, Tennigkeit F. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 15-21. PMID 21384431 DOI: 10.1002/Gps.2679 |
0.235 |
|
| 1997 |
Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease Alzheimer Disease & Associated Disorders. 11: 33-39. DOI: 10.1097/00002093-199700112-00005 |
0.234 |
|
| 2015 |
Isaacson RS, Ferris S, Velting DM, Meng X. Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease. American Journal of Alzheimer's Disease and Other Dementias. PMID 26371345 DOI: 10.1177/1533317515603687 |
0.234 |
|
| 1988 |
REISBERG B, FERRIS SH, FRANSSEN E, KLUGER A, BORENSTEIN J, DE LEON MJ. CLINICAL CHARACTERISTICS OF DEMENTIA OF THE ALZHEIMER TYPE (AD) Alzheimer Disease & Associated Disorders. 2: 155. DOI: 10.1097/00002093-198802030-00003 |
0.234 |
|
| 1992 |
Smith GS, de Leon MJ, George AE, Kluger A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Ciaravino J. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Archives of Neurology. 49: 1142-50. PMID 1444881 DOI: 10.1001/Archneur.1992.00530350056020 |
0.232 |
|
| 2014 |
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. The New England Journal of Medicine. 370: 322-33. PMID 24450891 DOI: 10.1056/Nejmoa1304839 |
0.232 |
|
| 1984 |
Georgotas A, Reisberg B, Ferris S. First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patients. Archives of Gerontology and Geriatrics. 2: 249-54. PMID 6651397 DOI: 10.1016/0167-4943(83)90028-6 |
0.231 |
|
| 1982 |
Reisberg B, Ferris SH. Diagnosis and assessment of the older patient. Hospital & Community Psychiatry. 33: 104-10. PMID 7056516 DOI: 10.1176/PS.33.2.104 |
0.231 |
|
| 2004 |
Golomb J, Kluger A, Ferris SH. Mild cognitive impairment: historical development and summary of research. Dialogues in Clinical Neuroscience. 6: 351-67. PMID 22034453 |
0.23 |
|
| 2010 |
Doody RS, Ferris S, Salloway S, Yijun Sun, Goldman R, Yikang Xu, Gao J, Murthy AK. Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study. American Journal of Alzheimer's Disease and Other Dementias. 25: 155-9. PMID 19949165 DOI: 10.1177/1533317509352334 |
0.229 |
|
| 2005 |
Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology. 63: 651-7. PMID 15326237 DOI: 10.1212/01.WNL.0000134664.80320.92 |
0.229 |
|
| 2009 |
Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology. 72: 1555-61. PMID 19176895 DOI: 10.1212/01.wnl.0000344650.95823.03 |
0.227 |
|
| 1983 |
de Leon MJ, Ferris SH, George AE, Reisberg B, Christman DR, Kricheff II, Wolf AP. Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 3: 391-4. PMID 6603463 DOI: 10.1038/Jcbfm.1983.57 |
0.227 |
|
| 2012 |
Ferris S, Mackell J, Bai Z, Sun Y. P3-387: Assessing language function using the severe impairment battery (SIB) and mini-mental state examination (MMSE): Correlation analysis in patients with moderate-to-severe Alzheimer's disease Alzheimer's & Dementia. 8: P591-P591. DOI: 10.1016/j.jalz.2012.05.1612 |
0.227 |
|
| 2005 |
Clark CM, DeCarli C, Mungas D, Chui HI, Higdon R, Nuñez J, Fernandez H, Negrón M, Manly J, Ferris S, Perez A, Torres M, Ewbank D, Glosser G, van Belle G. Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Archives of Neurology. 62: 774-8. PMID 15883265 DOI: 10.1001/Archneur.62.5.774 |
0.226 |
|
| 1989 |
de Leon MJ, George AE, Reisberg B, Ferris SH, Kluger A, Stylopoulos LA, Miller JD, La Regina ME, Chen C, Cohen J. Alzheimer's disease: longitudinal CT studies of ventricular change. Ajr. American Journal of Roentgenology. 152: 1257-62. PMID 2785749 DOI: 10.2214/ajr.152.6.1257 |
0.226 |
|
| 2012 |
Lau H, Karantzoulis S, Myers C, Pirraglia E, Li Y, Gurnani A, Glodzik L, Scharfman H, Kesner R, De Leon M, Ferris S. P2-274: Cognitive detection of preclinical Alzheimer's disease Alzheimer's & Dementia. 8: P358-P358. DOI: 10.1016/J.Jalz.2012.05.982 |
0.226 |
|
| 2012 |
Karantzoulis S, Pirraglia E, De Leon M, Ferris S, Randolph C. P1-017: Predicting 12- and 24-month progression in mild cognitive impairment: Comparison of neurocognitive, neuroanatomical and CSF biomarker data Alzheimer's & Dementia. 8: P113-P113. DOI: 10.1016/j.jalz.2012.05.292 |
0.225 |
|
| 1979 |
de Leon MJ, Ferris SH, Blau I, George AE, Reisberg B, Kricheff II, Gershon S. Correlations between computerised tomographic changes and behavioural deficits in senile dementia. Lancet (London, England). 2: 859-60. PMID 90961 DOI: 10.1016/S0140-6736(79)92217-7 |
0.225 |
|
| 2008 |
Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li MC, Goldman R. P1-187: Interrater reliability between expert and nonexpert physicians in the assessment of amnestic mild cognitive impairment in the community setting Alzheimer's & Dementia. 4: T263-T263. DOI: 10.1016/j.jalz.2008.05.775 |
0.223 |
|
| 1981 |
De Leon MJ, Ferris SH, George AE, Reisberg B, Kricheff II, Gershon S. Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type. Neurobiology of Aging. 1: 69-79. PMID 7266737 DOI: 10.1016/0197-4580(80)90027-5 |
0.22 |
|
| 1992 |
Prichep LS, John ER, Almas M, Ferris S, Reisberg B. Prediction of the evalution of cognitive deterioration in the elderly using QEEG European Neuropsychopharmacology. 2: 186. |
0.218 |
|
| 1984 |
REISBERG B, FERRIS SH, ANAND R, LEON MJ, SCHNECK MK, BUTTINGER C, BORENSTEIN J. Functional Staging of Dementia of the Alzheimer Type Annals of the New York Academy of Sciences. 435: 481-483. DOI: 10.1111/j.1749-6632.1984.tb13859.x |
0.217 |
|
| 2010 |
Santi SD, Pirraglia E, Ferris SH, Morris JC, Weintraub S, Johnson N. Robust norms for the ADC-UDS cognitive test battery Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1655 |
0.212 |
|
| 1980 |
Ferris SH, Leon MJd, Wolf AP, Farkas T, Christman DR, Reisberg B, Fowler JS, MacGregor R, Goldman A, George AE, Rampal S. Positron emission tomography in the study of aging and senile dementia. Neurobiology of Aging. 1: 127-131. PMID 24279935 DOI: 10.1016/0197-4580(80)90005-6 |
0.211 |
|
| 1989 |
de Leon MJ, George AE, Kluger A, Franssen E, Ferris SH, Wolf AP. PET-deoxyglucose, CT, and neuropathology of age-related white matter pathology in normals and Alzheimer's patients. Psychiatry Research. 29: 359-60. PMID 2608793 DOI: 10.1016/0165-1781(89)90089-9 |
0.21 |
|
| 2009 |
Ferris S, Darreh-Shori T, Lane R. P2-246: Effects of rivastigmine on brain white matter volume in Mild Cognitive Impairment (MCI) Alzheimer's & Dementia. 5: P332-P332. DOI: 10.1016/j.jalz.2009.04.559 |
0.21 |
|
| 1989 |
Reisberg B, Ferris SH, de Leon MJ, Kluger A, Franssen E, Borenstein J, Alba RC. The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. Progress in Clinical and Biological Research. 317: 23-41. PMID 2690101 |
0.21 |
|
| 2013 |
Ferris SH, Farlow M. Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. Clinical Interventions in Aging. 8: 1007-14. PMID 23946647 DOI: 10.2147/Cia.S39959 |
0.21 |
|
| 1982 |
Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. The American Journal of Psychiatry. 139: 352-3. PMID 6977276 DOI: 10.1176/Ajp.139.3.352 |
0.209 |
|
| 2011 |
Ferris SH, Schmitt FA, Saxton J, Richardson S, Mackell J, Sun Y, Xu Y. Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease. Alzheimer's Research & Therapy. 3: 22. PMID 21689411 DOI: 10.1186/Alzrt84 |
0.208 |
|
| 1996 |
Reisberg B, Franssen EH, Bobinski M, Auer S, Monteiro I, Boksay I, Wegiel J, Shulman E, Steinberg G, Souren LE, Kluger A, Torossian C, Sinaiko E, Wisniewski HM, Ferris SH. Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease. International Psychogeriatrics / Ipa. 8: 159-93. PMID 8994889 DOI: 10.1017/S1041610296002566 |
0.208 |
|
| 1981 |
Ferris SH, McCarthy M, Reisberg B, Gershon S, Bush D. Influence of zimelidine and imipramine on psychomotor skill and cognitive function Acta Psychiatrica Scandinavica. 63: 302-302. DOI: 10.1111/J.1600-0447.1981.TB00733.X |
0.204 |
|
| 2001 |
Monteiro IM, Boksay I, Auer SR, Torossian C, Ferris SH, Reisberg B. Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability. European Psychiatry : the Journal of the Association of European Psychiatrists. 16: 5s-24s. PMID 11520474 |
0.204 |
|
| 2010 |
Shankle WR, Fleisher A, Rafii M, Ferris SH, Petersen R, Aisen P. P3-446: Effect of list word presentation order on noise level in verbal memory tasks Alzheimer's & Dementia. 6: S584-S584. DOI: 10.1016/J.Jalz.2010.05.1988 |
0.204 |
|
| 2012 |
Benitez A, Fieremans E, Falangola MdF, Ferris S, Jensen J, Helpern JA. Cognitive processing speed and diffusional kurtosis imaging (DKI) in normal aging, mild cognitive impairment (MCI) and Alzheimer's disease Alzheimers & Dementia. 8: 42. DOI: 10.1016/J.Jalz.2012.05.103 |
0.204 |
|
| 2014 |
Guerrero-Berroa E, Kluger A, Schmeidler J, Sailor K, Lizardi H, Golomb J, Ferris S, Reisberg B. Neuropsychological and neuropsychiatric prediction of global cognitive status among older Spanish-speaking Hispanics and English-speaking whites. Journal of Geriatric Psychiatry and Neurology. 27: 266-75. PMID 24759088 DOI: 10.1177/0891988714532020 |
0.203 |
|
| 1996 |
Ferris SH, Khachaturian Z, Lebowitz B, Oderda G, Radebaugh T, Teresi J, Whitehouse P. Round Table Discussion: The Scientist's View on Outcome Methodologies for Pharmacologic Trials in Mild, Moderate, and Severe Alzheimer's Disease International Psychogeriatrics. 8: 343-344. DOI: 10.1017/S1041610296002700 |
0.201 |
|
| 2009 |
Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 375-9. PMID 19751916 DOI: 10.1016/J.Jalz.2009.04.1236 |
0.2 |
|
| 2006 |
Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. The American Journal of Geriatric Pharmacotherapy. 4: S9-S24; quiz S25-S28. PMID 17157793 DOI: 10.1016/j.amjopharm.2006.10.001 |
0.199 |
|
| 1983 |
Reisberg B, Ferris SH, Anand R, Mir P, Geibel V, De Leon MJ, Roberts E. Effects of naloxone in senile dementia: a double-blind trial. The New England Journal of Medicine. 308: 721-2. PMID 6338389 DOI: 10.1056/NEJM198303243081213 |
0.198 |
|
| 2009 |
Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 369-74. PMID 19751915 DOI: 10.1016/J.Jalz.2009.05.604 |
0.198 |
|
| 2013 |
Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS. Health-related resource use and costs in elderly adults with and without mild cognitive impairment. Journal of the American Geriatrics Society. 61: 396-402. PMID 23414481 DOI: 10.1111/Jgs.12132 |
0.198 |
|
| 1989 |
Reisberg B, Ferris SH, Franssen E, Jenkins EC, Wisniewski KE. Clinical features of a neuropathologically verified familial Alzheimer's cohort with onset in the fourth decade: comparison with senile onset Alzheimer's disease and etiopathogenic implications. Progress in Clinical and Biological Research. 317: 43-54. PMID 2690108 |
0.197 |
|
| 2002 |
Fillit HM, O'Connell AW, Brown WM, Altstiel LD, Anand R, Collins K, Ferris SH, Khachaturian ZS, Kinoshita J, Van Eldik L, Dewey CF. Barriers to drug discovery and development for Alzheimer disease. Alzheimer Disease and Associated Disorders. 16: S1-8. PMID 12070355 |
0.196 |
|
| 2011 |
Aisen PS, Gauthier S, Ferris SH, Saumier D, Haine D, Garceau D, Duong A, Suhy J, Oh J, Lau WC, Sampalis J. Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study). Archives of Medical Science : Ams. 7: 102-11. PMID 22291741 DOI: 10.5114/Aoms.2011.20612 |
0.194 |
|
| 1997 |
Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD, Morris JC, Oakley F, Schneider LS, Streim JE, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. Jama. 278: 1363-71. PMID 9343469 DOI: 10.1001/Jama.1997.03550160083043 |
0.194 |
|
| 1997 |
Ferris SH, Mackell JA. Behavioral outcomes in clinical trials for Alzheimer disease. Alzheimer Disease and Associated Disorders. 11: S10-5. PMID 9339267 |
0.194 |
|
| 1997 |
Ferris SH, Lucca U, Mohs R, Dubois B, Wesnes K, Erzigkeit H, Geldmacher D, Bodick N. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Disease and Associated Disorders. 11: 34-8. PMID 9305514 |
0.193 |
|
| 2006 |
Reisberg B, Franssen E, Zhu W, Torossian C, Monteiro I, Boksay I, Ferris S. P1-373: Etiopathogenic import of the utility of a neurodevelopmental functional measure in Alzheimer's disease (AD) assessment Alzheimer's & Dementia. 2: S207-S207. DOI: 10.1016/j.jalz.2006.05.751 |
0.191 |
|
| 2002 |
Grundman M, Farlow M, Peavy G, Kim HT, Capparelli E, Schultz AN, Salmon DP, Ferris SH, Mobs R, Thomas RG, Schafer K, Campbell K, Hake AM, Schoos B, Thal LJ, et al. A phase I study of AIT-082 in healthy elderly volunteers. Journal of Molecular Neuroscience : Mn. 18: 283-93. PMID 12059047 DOI: 10.1385/Jmn:18:3:283 |
0.191 |
|
| 1993 |
Mittelman MS, Ferris SH, Steinberg G, Shulman E, Mackell JA, Ambinder A, Cohen J. An intervention that delays institutionalization of alzheimer's disease patients: Treatment of spouse-caregivers Gerontologist. 33: 730-740. PMID 8314099 DOI: 10.1093/geront/33.6.730 |
0.19 |
|
| 2013 |
Fieremans E, Benitez A, Jensen JH, Falangola MF, Tabesh A, Deardorff RL, Spampinato MVS, Babb JS, Novikov DS, Ferris SH, Helpern JA. Novel white matter tract integrity metrics sensitive to Alzheimer disease progression American Journal of Neuroradiology. 34: 2105-2112. PMID 23764722 DOI: 10.3174/Ajnr.A3553 |
0.19 |
|
| 2000 |
Ferris SH, Kluger A, Golomb J, Reisberg B. Neuropsychological correlates of early Alzheimer's disease Neurobiology of Aging. 21: 72. DOI: 10.1016/S0197-4580(00)82544-0 |
0.19 |
|
| 1983 |
George AE, de Leon MJ, Rosenbloom S, Ferris SH, Gentes C, Emmerich M, Kricheff II. Ventricular volume and cognitive deficit: a computed tomographic study. Radiology. 149: 493-8. PMID 6622694 DOI: 10.1148/radiology.149.2.6622694 |
0.188 |
|
| 2010 |
Robert P, Ferris S, Gauthier S, Ihl R, Winblad B, Tennigkeit F. Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimer's Research & Therapy. 2: 24. PMID 20796301 DOI: 10.1186/Alzrt48 |
0.184 |
|
| 2003 |
Ferris SH. Evaluation of memantine for the treatment of Alzheimer's disease. Expert Opinion On Pharmacotherapy. 4: 2305-13. PMID 14640929 DOI: 10.1517/14656566.4.12.2305 |
0.183 |
|
| 2003 |
Myers CE, Shohamy D, Gluck MA, Grossman S, Kluger A, Ferris S, Golomb J, Schnirman G, Schwartz R. Dissociating hippocampal versus basal ganglia contributions to learning and transfer. Journal of Cognitive Neuroscience. 15: 185-93. PMID 12676056 DOI: 10.1162/089892903321208123 |
0.182 |
|
| 2010 |
Reisberg B, Jamil IA, Khan S, Monteiro I, Torossian C, Ferris S, Sabbagh M, Gauthier S, Auer S, Shulman MB, Kluger A, Franssen E, Wegiel J. Staging Dementia Principles and Practice of Geriatric Psychiatry: Third Edition. 162-169. DOI: 10.1002/9780470669600.ch31 |
0.181 |
|
| 2000 |
Reisberg B, Windscheif U, Ferris SH, Hingorani VN, Stoeffler A, Moebius H. Memantine in moderately severe to severe Alzheimer's disease (AD): Results of a placebo-controlled 6-month trial Neurobiology of Aging. 21: 275. DOI: 10.1016/S0197-4580(00)83188-7 |
0.18 |
|
| 2006 |
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Archives of Neurology. 63: 49-54. PMID 16401736 DOI: 10.1001/Archneur.63.1.49 |
0.18 |
|
| 2000 |
Reisberg B, Ferris S, Sahin K, Windscheif U, Möbius H. Results of a placebo-controlled 6-month trial with memantine in moderate to severe Alzheimer's disease (AD) European Neuropsychopharmacology. 10: 363-364. DOI: 10.1016/S0924-977X(00)80482-4 |
0.179 |
|
| 2011 |
Holthoff VA, Ferris S, Ihl R, Robert P, Winblad B, Gauthier S, Sternberg K, Tennigkeit F. Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice. Alzheimer's Research & Therapy. 3: 27. PMID 21914212 DOI: 10.1186/Alzrt89 |
0.176 |
|
| 1993 |
de Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, De Santi S, Smith G, Ferris SH, Noz M. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. Ajnr. American Journal of Neuroradiology. 14: 897-906. PMID 8352162 |
0.175 |
|
| 1997 |
Smyth KA, Ferris SH, Fox P, Heyman A, Holmes D, Morris JN, Phillips CD, Schulz R, Teresi J, Whitehouse PJ. Measurement choices in multi-site studies of outcomes in dementia. Alzheimer Disease and Associated Disorders. 11: 30-44. PMID 9437446 |
0.174 |
|
| 1986 |
Reisberg B, Borenstein J, Franssen E, Shulman E, Steinberg G, Ferris SH. Remediable behavioral symptomatology in Alzheimer's disease Hospital and Community Psychiatry. 37: 1199-1201. PMID 3804220 DOI: 10.1176/PS.37.12.1199 |
0.173 |
|
| 2014 |
Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Galasko D, Schneider LS, Aisen PS. Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. Journal of the American Geriatrics Society. 62: 985-8. PMID 24828933 DOI: 10.1111/Jgs.12816 |
0.173 |
|
| 1982 |
Pomara N, Reisberg B, Albers S, Ferris S, Gershon S. Extrapyramidal symptoms in patients with primary degenerative dementia. Journal of Clinical Psychopharmacology. 1: 398-400. PMID 7334150 DOI: 10.1097/00004714-198111000-00010 |
0.172 |
|
| 2008 |
Falangola MF, Jensen JH, Babb JS, Hu C, Castellanos FX, Di Martino A, Ferris SH, Helpern JA. Age-related non-Gaussian diffusion patterns in the prefrontal brain. Journal of Magnetic Resonance Imaging : Jmri. 28: 1345-50. PMID 19025941 DOI: 10.1002/Jmri.21604 |
0.172 |
|
| 1988 |
DE LEON MJ, GEORGE AE, FERRIS SH, REISBERG B, WOLF AP. PET-DEOXYGLUCOSE, CT AND NEUROPATHOLOGY STUDIES OF AGE RELATED WHITE MATTER PATHOLOGY IN NORMALS AND ALZHEIMER DISEASE Alzheimer Disease & Associated Disorders. 2: 158. DOI: 10.1097/00002093-198802030-00006 |
0.172 |
|
| 1999 |
Ferris SH, Hofeldt GT, Carbone G, Masciandaro P, Troetel WM, Imbimbo BP. Suicide in two patients with a diagnosis of probable Alzheimer disease. Alzheimer Disease and Associated Disorders. 13: 88-90. PMID 10372951 |
0.166 |
|
| 1992 |
Reisberg B, Ferris SH, Torossian C, Kluger A, Monteiro I. Pharmacologic treatment of Alzheimer's disease: a methodologic critique based upon current knowledge of symptomatology and relevance for drug trials. International Psychogeriatrics. 4: 9-42. PMID 1504291 |
0.166 |
|
| 2013 |
Ferris S, Cummings J, Christensen D, Doody R, Farlow M, Sabbagh M, Liu L, Mackell J, Fain R. Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity. Alzheimer's Research & Therapy. 5: 12. PMID 23433097 DOI: 10.1186/Alzrt166 |
0.165 |
|
| 1992 |
Ferris SH. Alzheimer's disease. Diagnosis by specialists: psychological testing. Acta Neurologica Scandinavica. Supplementum. 139: 32-5. PMID 1414266 DOI: 10.1111/j.1600-0404.1992.tb04451.x |
0.165 |
|
| 2012 |
Ferris S, Mackell J, Bai Z, Sun Y. P3-388: Effect of donepezil 23 mg/day on language function in patients with moderate-to-severe Alzheimer's disease (AD): Subgroup analysis of United States (U.S.)-based patients Alzheimer's & Dementia. 8: P591-P592. DOI: 10.1016/j.jalz.2012.05.1613 |
0.164 |
|
| 1996 |
Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A Family Intervention to Delay Nursing Home Placement of Patients With Alzheimer Disease: A Randomized Controlled Trial Jama. 276: 1725-1731. DOI: 10.1001/Jama.1996.03540210033030 |
0.162 |
|
| 1996 |
Mittelman MS, Ferris SH, Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home placement of patients with Alzheimer disease: A randomized controlled trial Journal of the American Medical Association. 276: 1725-1731. PMID 8940320 |
0.162 |
|
| 2006 |
Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Disease and Associated Disorders. 20: S124-38. PMID 17135806 DOI: 10.1097/01.Wad.0000213878.47924.44 |
0.161 |
|
| 2001 |
Morris JC, Farlow MR, Ferris SH, Kurz AF, Maelicke A, Rasmusen L, Wilkinson D, Yan B. Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers. Clinical Therapeutics. 23: A31-9. PMID 11396870 DOI: 10.1016/S0149-2918(01)80166-1 |
0.16 |
|
| 1992 |
Reisberg B, Ferris SH, Torossian C, Kluger A, Monteiro I. Pharmacologic Treatment of Alzheimer's Disease: A Methodologic Critique Based Upon Current Knowledge of Symptomatology and Relevance for Drug Trials International Psychogeriatrics. 4: 9-42. DOI: 10.1017/S1041610292001133 |
0.159 |
|
| 1990 |
Reisberg B, Sclan S, Franssen E, Ferris S. Pharmacotherapy of Alzheimer's disease: present opportunities and future possibilities European Journal of Pharmacology. 183: 83. DOI: 10.1016/0014-2999(90)91340-H |
0.156 |
|
| 1987 |
Miller J, de Leon M, Ferris S, Kluger A, George A, Reisberg B, Sachs H, Wolf A. Abnormal temporal lobe response in Alzheimerʼs disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET Alzheimer Disease & Associated Disorders. 1: 269. DOI: 10.1097/00002093-198701040-00030 |
0.156 |
|
| 2002 |
Hartvig P, Nordberg A, Torstenson R, Sjöberg P, Fasth KJ, Pettersson AF, Engardt M, Wahlund L, Liu H, Teng EL, Lin K, Chuang Y, Wang P, Fuh J, Liu C, ... ... Ferris SH, et al. Subject Index Vol. 13, 2002 Dementia and Geriatric Cognitive Disorders. 13: 250-250. DOI: 10.1159/000057705 |
0.155 |
|
| 1984 |
de Leon MJ, George AE, Ferris SH, Christman DR, Fowler JS, Gentes CI, Brodie J, Reisberg B, Wolf AP. Positron emission tomography and computed tomography assessments of the aging human brain. Journal of Computer Assisted Tomography. 8: 88-94. PMID 6606657 DOI: 10.1097/00004728-198402000-00017 |
0.154 |
|
| 1995 |
Mitchel Y, Kramer M, Matzura-Wolfe D, Strittmatter W, Peskind E, Ferris S, Galasko D, Sano M, Marin D, Clark C. The effect of simvastatin on cerebrospinal fluid levels of apolipoprotein E in patients with alzheimer's disease Atherosclerosis. 115: S113. DOI: 10.1016/0021-9150(95)96682-I |
0.15 |
|
| 2011 |
Sano M, Egelko S, Ferris S, Kaye J, Hayes T, Mundt J, Reyes T, Donohue M, Sun C, Whitehair D, Stokes K, Aisen P. Alzheimer disease cooperative study (ADCS) home based assessment: Designing trials with new technology Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1434 |
0.149 |
|
| 2004 |
Stöffler A, Ferris SH, Wirth Y, Reisberg B. P1-399 Responders to memantine treatment in moderate to severe Alzheimer's disease Neurobiology of Aging. 25: S212. DOI: 10.1016/S0197-4580(04)80711-5 |
0.149 |
|
| 1990 |
Ferris SH. Therapeutic strategies in dementia disorders. Acta Neurologica Scandinavica. Supplementum. 129: 23-6. PMID 2171297 |
0.147 |
|
| 2014 |
Benitez A, Fieremans E, Jensen JH, Falangola MF, Tabesh A, Ferris SH, Helpern JA. White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease. Neuroimage. Clinical. 4: 64-71. PMID 24319654 DOI: 10.1016/J.Nicl.2013.11.001 |
0.147 |
|
| 1996 |
Whitehouse P, Amaducci L, Feldman H, Ferris S, Gauthier S, Homma A, Khachaturian Z, Levy R, Orgogozo J, Post S, Reisberg B, Rossor M, Thal L, Winblad B. 9 International working group on harmonization of dementia drug guidelines Neurobiology of Aging. 17: S3. DOI: 10.1016/S0197-4580(96)80011-X |
0.146 |
|
| 2006 |
Ferris SH. Supplement editorial: alzheimer disease. Alzheimer Disease and Associated Disorders. 20: S107-8. PMID 17135804 DOI: 10.1097/01.wad.0000213875.63171.87 |
0.145 |
|
| 1997 |
Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) Alzheimer Disease & Associated Disorders. 11: 425-429. DOI: 10.1007/978-1-4612-4116-4_64 |
0.143 |
|
| 2002 |
Pomara N, Doraiswamy PM, Tun H, Ferris S. Mifepristone (RU 486) for Alzheimer's disease. Neurology. 58: 1436. PMID 12011303 DOI: 10.1212/WNL.58.9.1436 |
0.141 |
|
| 1995 |
Ferris SH, Hasegawa K, Homma A, Khachaturian ZS, Post S, Rossor M, Whitehouse PJ. International efforts to improve Alzheimer disease treatment Alzheimer Disease and Associated Disorders. 9: 181. |
0.137 |
|
| 1987 |
Ferris SH, Steinberg G, Shulman E, Kahn R, Reisberg B. Institutionalization of alzheimer’s disease patients: Reducing precipitating factors through family counseling Home Health Care Services Quarterly. 8: 23-51. PMID 10317902 DOI: 10.1300/J027v08n01_03 |
0.137 |
|
| 1983 |
Alavi A, Reivich M, Ferris S, Christman D, Fowler J, MacGregor R, Farkas T, Greenberg J, Dann R, Wolf A. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. Experimental Brain Research. 187-95. PMID 6983979 DOI: 10.1007/978-3-642-68507-1_26 |
0.136 |
|
| 1986 |
Reisberg B, Ferris SH. Emergency Issues in the Assessment and Management of Alzheimer's Disease Emergency Health Services Review. 3: 55-76. DOI: 10.1300/J261v03n01_06 |
0.135 |
|
| 1982 |
Schneck MK, Reisberg B, Ferris SH. An overview of current concepts of Alzheimer's disease. The American Journal of Psychiatry. 139: 165-73. PMID 6119911 DOI: 10.1176/AJP.139.2.165 |
0.134 |
|
| 2009 |
Saumier D, Aisen PS, Gauthier S, Vellas B, Ferris SH, Duong A, Suhy J, Oh J, Lau W, Garceau D, Haine D, Sampalis J. Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience. The Journal of Nutrition, Health & Aging. 13: 370-2. PMID 19300884 DOI: 10.1007/S12603-009-0047-4 |
0.128 |
|
| 1993 |
Reisberg H, Ferris SH, Sclan SG. Empirical evaluation of the global deterioration scale for staging Alzheimer's disease. The American Journal of Psychiatry. 150: 680-2. PMID 8465902 DOI: 10.1176/ajp.150.4.aj1504680 |
0.125 |
|
| 1996 |
Ferris SH, Mittelman MS. Behavioral treatment of Alzheimer's disease. International Psychogeriatrics. 8: 87-90. PMID 8934272 |
0.124 |
|
| 2002 |
Ferris SH. Clinical trials in AD: are current formats and outcome measures adequate? Alzheimer Disease and Associated Disorders. 16: S13-7. PMID 12070357 |
0.123 |
|
| 2009 |
Robert P, Ferris S, Gauthier S, Gatz G, Winblad B, Tennigkeit F. The need for a new practical Alzheimer's disease scale Alzheimers & Dementia. 5: 186. DOI: 10.1016/J.Jalz.2009.04.052 |
0.123 |
|
| 1988 |
FERRIS SH, FLICKER C, KLUGER A, REISBERG B. NOVEL THERAPEUTIC STRATEGIES FOR ALZHEIMER??S DISEASE AND RELATED DISORDERS Alzheimer Disease & Associated Disorders. 2: 207. DOI: 10.1097/00002093-198802030-00056 |
0.122 |
|
| 2006 |
Clelland CL, Ferris SH, Read LL, Clelland JD, Cocchiola J, Waters R, Oo T, Vedvyas A. P3-097: Classifying Alzheimer's disease through multigene expression signature profiling Alzheimer's & Dementia. 2: S401-S402. DOI: 10.1016/j.jalz.2006.05.1364 |
0.12 |
|
| 1990 |
Serby M, Flicker C, Rypma B, Weber S, Rotrosen JP, Ferris SH. Scopolamine and olfactory function. Biological Psychiatry. 28: 79-82. PMID 2165425 DOI: 10.1016/0006-3223(90)90435-5 |
0.119 |
|
| 1982 |
Ferris SH. The Tenth Aharon Katzir-Katchalsky Conference on the Aging of the Brain Neurobiology of Aging. 3: 149-151. DOI: 10.1016/0197-4580(82)90012-4 |
0.118 |
|
| 2001 |
Ferris SH. Switching previous therapies for Alzheimer's disease to galantamine. Clinical Therapeutics. 23: A3-7. PMID 11396869 |
0.118 |
|
| 1996 |
Ferris S. 185 Behavioral outcomes in clinical trials on drug therapy for Alzheimers disease Neurobiology of Aging. 17: S47. DOI: 10.1016/S0197-4580(96)80187-4 |
0.111 |
|
| 1995 |
Mittelman MS, Ferris SH, Shulman E, Steinberg G, Ambinder A, Mackell JA, Cohen J. A comprehensive support program: Effect on depression in spouse-caregivers of AD patients Gerontologist. 35: 792-802. PMID 8557206 |
0.111 |
|
| 2004 |
Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. The Journal of Clinical Endocrinology and Metabolism. 89: 2271-4. PMID 15126552 DOI: 10.1210/jc.2003-032150 |
0.109 |
|
| 2014 |
Benitez A, Fieremans E, Jensen JH, Falangola MF, Tabesh A, Ferris SH, Helpern JA. White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease Neuroimage: Clinical. 4: 64-71. DOI: 10.1016/j.nicl.2013.11.001 |
0.108 |
|
| 1997 |
Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. Multicenter Evaluation of New Instruments for Alzheimerʼs Disease Clinical Trials Alzheimer Disease & Associated Disorders. 11: 65-69. DOI: 10.1097/00002093-199700112-00010 |
0.105 |
|
| 1997 |
Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimerʼs Disease Clinical Trials Alzheimer Disease & Associated Disorders. 11: 1-12. DOI: 10.1097/00002093-199700112-00002 |
0.104 |
|
| 1996 |
Ferris SH, Whitehouse PJ. Advances in Drug Development: The Role of Alzheimer Disease and Associated Disorders Alzheimer Disease & Associated Disorders. 10: 121. DOI: 10.1097/00002093-199601030-00001 |
0.101 |
|
| 2003 |
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. The New England Journal of Medicine. 348: 1333-41. PMID 12672860 DOI: 10.1056/Nejmoa013128 |
0.095 |
|
| 1990 |
Ribary U, Llinás R, Kluger A, Cappell J, Suk J, Ferris S. Dynamics of magnetic, auditory evoked steady-state responses in Alzheimer patients Electroencephalography and Clinical Neurophysiology. 75: S126. DOI: 10.1016/0013-4694(90)92180-5 |
0.094 |
|
| 1981 |
Ferris SH, Reisberg B. Clinical trials: Neuropeptides and nootropics Neurobiology of Aging. 2: 71. DOI: 10.1016/0197-4580(81)90068-3 |
0.079 |
|
| 2008 |
Fokkens J, Ferris S, Robert P, Winblad B, Gauthier S. P4-365: Assessment of memantine treatment effects on language Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2436 |
0.079 |
|
| 2006 |
Carmichael JD, Danoff A, Milani D, Roubenoff R, Lesser ML, Livote E, Reitz RE, Ferris S, Kleinberg DL. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clinical Endocrinology. 65: 169-77. PMID 16886956 DOI: 10.1111/j.1365-2265.2006.02569.x |
0.078 |
|
| 1984 |
de Leon MJ, George AE, Ferris SH, Christman D, Gentes CI, Miller JD, Fowler J, Reisberg B, Woif AP. CT, PET AND NUR BRAIN IMAGING IN AGING AND ALZHEIMERʼS DISEASE Clinical Neuropharmacology. 7: S179. DOI: 10.1097/00002826-198406001-00164 |
0.074 |
|
| 1983 |
de Leon MJ, George AE, Ferris SH, Rosenbloom S, Christman DR, Fowler J, Gentes C, Gee B, Reisberg B, Kricheff II, Wolf A. POSITRON EMISSION TOMOGRAPHY (PET) AND COMPUTED TOMOGRAPHY (CT) EVALUATIONS COMBINED IN THE STUDY OF SENILE DEMENTIA OF THE ALZHEIMERʼS TYPE Journal of Computer Assisted Tomography. 7: 186. DOI: 10.1097/00004728-198302000-00086 |
0.068 |
|
| 2000 |
Golomb J, Ferris SH. Pathophygiologic heterogeneity or differences in premorbid vulnerability? Neurobiology of Aging. 21: 871-2; discussion 87. PMID 11124433 |
0.064 |
|
| 1976 |
FERRIS S, CROOK T, SATHANANTHAN G, GERSHON S. Reaction Time as a Diagnostic Measure in Senility* Journal of the American Geriatrics Society. 24: 529-533. DOI: 10.1111/j.1532-5415.1976.tb03277.x |
0.059 |
|
| 2006 |
Pomara N, Hernando RT, de la Pena CB, Sidtis JJ, Cooper TB, Ferris S. The Effect of Mifepristone (RU 486) on Plasma Cortisol in Alzheimer’s Disease Neurochemical Research. 31: 585-588. DOI: 10.1007/s11064-006-9055-5 |
0.043 |
|
| 2019 |
King E, Champan D, Luo K, Ferris S, Huang G, Mitchell AE. Defining the sensory profiles of raw almond (Prunus dulcis) varieties and the contribution of key chemical compounds and physical properties. Journal of Agricultural and Food Chemistry. PMID 30798590 DOI: 10.1021/Acs.Jafc.8B05845 |
0.03 |
|
| 1978 |
Campbell M, Hollander CS, Ferris S, Greene LW. Response to thyrotropin-releasing hormone stimulation in young psychotic children: a pilot study. Psychoneuroendocrinology. 3: 195-201. PMID 100804 DOI: 10.1016/0306-4530(78)90008-2 |
0.03 |
|
| 1981 |
Ferris SH. Your Brain Is Younger Than You Think Journal of Gerontology. 36: 755-755. DOI: 10.1093/GERONJ/36.6.755A |
0.028 |
|
| 2004 |
Ferris S, Aisen P, Galasko D, Salmon D, Schneider L, Sano M, Whitehouse P. P1-407 ADCS prevention instrument project: overview and initial results Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80719-X |
0.024 |
|
| 1997 |
Sano M, Mackell JA, Ponton M, Ferreira P, Wilson J, Pawluczyk S, Pfeiffer E, Thomas RG, Jin S, Schafer K, Schittini M, Grundman M, Ferris SH, Thal LJ. The Spanish Instrument Protocol Alzheimer Disease & Associated Disorders. 11: 57-64. DOI: 10.1097/00002093-199700112-00009 |
0.024 |
|
| 2000 |
Ferris SH, Sinaiko EA, Faiz S, Monteiro IM, Reisberg B, Windscheif U, Stoeffler A. Effects of a rater training program on the clinician interview based impression of change (cibic-plus) Neurobiology of Aging. 21: 27. DOI: 10.1016/S0197-4580(00)82797-9 |
0.023 |
|
| 2006 |
Reisberg B, Doody R, Schmitt F, Ferris S. Open-Label Extension Studies and Misinformation—Reply Archives of Neurology. 63: 1036. DOI: 10.1001/Archneur.63.7.1036-B |
0.014 |
|
| 2002 |
Hartvig P, Nordberg A, Torstenson R, Sjöberg P, Fasth KJ, Pettersson AF, Engardt M, Wahlund L, Liu H, Teng EL, Lin K, Chuang Y, Wang P, Fuh J, Liu C, ... ... Ferris SH, et al. Contents Vol. 13, 2002 Dementia and Geriatric Cognitive Disorders. 13: 251-251. DOI: 10.1159/000057706 |
0.01 |
|
| Hide low-probability matches. |